This multisession course considers the clinical potential of molecular imaging in management of cardiovascular diseases. Experts review molecular methods for imaging plaque, stem cell labeling for noninvasive imaging, the future of cardiovascular molecular imaging and more.

This multisession course focuses on the spectrum of breast imaging including genomic and pathologic features of breast cancer subtypes, current and future directions in nuclear medicine breast imaging and current and future roles of whole-body PET.

This course presents the basics of molecular imaging, reviews molecular imaging probes and explores theranostics as well as future directions in molecular imaging. It addresses systems diagnostics, bioinformatics and quantitative medical imaging.

Embattled University of Iowa radiology department head Laurie L. Fajardo, MD, MBA will be stepping down from her position effective Jan. 1, but will remain a faculty member.

Molecular is radiologys rising star, a point evidenced by its central role at the 97th Annual Meeting & Scientific Assembly of the RSNA. The New Horizons lecture, for example, dives into PET/MR, 7T MRI and more. With a dizzying array of sessions dedicated to molecular imaging, business intelligence is key. Scroll down for Health Imaging's top picks for RSNA sessions in molecular imaging and read on for a quick review of 2011 highlights in molecular imaging. Also, be sure to subscribe to our monthly molecular imaging portal to stay on top of these issues throughout the year.

The FDAs Circulatory Systems Devices advisory panel met Oct. 27 and voted against the Medtronic Phased RF Ablation System, an atrial fibrillation (AF) ablation therapy under investigation for the treatment of persistent and long-standing persistent AF.

Having comparison mammograms on hand has generally been thought to increase the accuracy of cancer detection during breast imaging, and a study published in the Oct. 26 issue of Radiology confirmed some of these benefits, but it also cautioned against a high false-positive rate when changes are noted between current and prior screening mammograms.

The International Contrast Ultrasound Society (ICUS) has applauded the FDAs decision to modify the U.S. product label for Definity Injectable Suspension, an ultrasound contrast agent.